sportspeptide.comA reader’s bulletin
Care. Claims. Competition.
A reading guide to care, costs and the rules of sport.
You can be curious without taking a sales pitch on trust. Pin down the medicine, the evidence and who is responsible for your care.
Compare what’s being offeredKeep these apart
Product map
Think of proteins as long strings made from pieces called amino acids. A peptide is a short string of those same pieces. Insulin belongs to this group.
Calling something a peptide settles neither safety nor whether the law allows it.
For a sports injury, ask what evidence supports the exact treatment for your exact problem. A broad promise of “recovery” leaves that question open.
When checking an approval claim, look to the Food and Drug Administration (FDA).
The US approval record checked September 26, 2026 includes semaglutide (Ozempic, Wegovy). Ozempic injection’s uses include controlling blood sugar in type 2 diabetes. Wegovy’s uses include weight management alongside changes to food and activity.
Ask which use and which product label match the proposed care.
With compounding, a pharmacist or doctor puts the medicine together for a patient’s needs.
US rules allowed some compounding as of September 26, 2026, with limits on ingredients and circumstances.
That preparation is not FDA-approved, and the agency does not check its safety, quality or ability to work before sale.
FDA letters checked September 26, 2026 challenged research-labelled products pitched as treatments for people. The agency said these were unapproved drugs despite the labels.
Those letters set out FDA’s accusations that federal drug law had been broken; they were not decisions by a court.
A label saying “research” is no answer to a question about treatment.
Eligibility map
At the September 26, 2026 check, WADA—the World Anti-Doping Agency—was using its 2026 list of banned substances.
Put the proposed medicine beside your sport’s rulebook before choosing a care plan.
| Name on the offer | What the sport record says |
|---|---|
| BPC-157 |
For the 2026 rules, WADA names BPC-157 in S0, its group for non-approved substances. S0 covers substances with no government approval for treating people anywhere in the world. If another section already covers the substance, WADA uses that section instead. That group’s ban applies both in competition and outside it. Ask your sport’s rules staff which section covers the exact ingredient and what that means for you. |
| TB-500 |
In WADA’s 2026 rules, TB-500 is banned as a growth factor—a substance that affects how parts of the body grow or repair. That ban covers competition and the time outside it. |
| Other recovery offers |
Sermorelin, CJC-1295 and ipamorelin prompt the body to release growth hormone, a chemical messenger involved in growth. WADA’s 2026 rules ban these substances at all times. If one is suggested for recovery, ask what evidence supports that use. |
Tirzepatide has US-approved injections for type 2 diabetes and for weight management, according to the September 26, 2026 record.
At the September 26, 2026 check, WADA tracked the use of semaglutide and tirzepatide through a watch list. Neither medicine was named on its banned list.
Being watched is neither a ban nor permission to use a treatment.
College athletes have a separate rulebook: the National Collegiate Athletic Association (NCAA) named BPC-157 and TB-500 on its 2026–27 list.
Even an unnamed substance can be banned if it resembles a banned group in its make-up or its effect on the body.
Give the exact ingredient name to your college sports staff and ask which rule covers it.
The published replacement for WADA’s 2026 list takes effect on January 1, 2027; it was not yet in force at the September 26, 2026 check.
WADA’s next rulebookCare map
Bring the concern, not just a request for a named peptide. Write down what is bothering you, what you hope will change and the medicines or supplements you take.
For remote care, the September 26, 2026 licensing guidance looks to where the patient is during the visit.
Check that the doctor has that state’s licence or another form of permission its rules accept; only limited exceptions apply.
For an online form with set questions and answer choices, prescribing rules depend on the state; that was still true on September 26, 2026.
Before paying, get the name of the person reviewing the form. Ask how to talk through answers that need more explanation.
The Federation of State Medical Boards publishes care recommendations for the boards overseeing doctors. In advice checked September 26, 2026, that group rejects care based on a treatment menu alone. Patients also need a chance to put their own further questions to the person giving care, the guidance says.
That guidance gives recommendations; the rules doctors must obey come from each state.
State medical boards publish licence records and records of doctors disciplined by the board—meaning it took action over their conduct.
Those records show public board action, not a rating of the care.
Get the doctor’s full name and licence details. Choose the state board based on your location for the visit. Match the name and licence details to its record.
Find the right medical boardFor a proposed prescription, ask which pharmacy will prepare or send it. Get its name before paying, then look up that name with the state pharmacy board.
Find a pharmacy licence through FDACost map
Ask for a written quote that names the medicine and the care included. A low advertised price leaves a lot unanswered.
A monthly fee may cover the service while leaving the medicine bill separate. That was common on the small set of weight-management websites checked September 26, 2026.
Those websites offered help with weight management; their prices do not tell you what treating a sports injury would cost.
“Prior authorization” is an insurer’s advance agreement to pay for a proposed prescription.
Ask who handles that step and what you owe if it says no.
Recovery pitches deserve scrutiny
For US prescription medicines, supplying them without a valid prescription broke federal law as of September 26, 2026.
A National Drug Code (NDC) is a product’s number in FDA’s drug directory. In the September 26, 2026 record, neither that number nor registration with FDA proved that a product was approved.
Match the named product to FDA’s record of approval.
Source route
Open the source that answers your question. Keep the exact product name beside it, and check which date and sport the record covers.
Some groups took back requests asking FDA to allow peptide ingredients in pharmacy-made medicines. On FDA’s page dated April 22, 2026, safety concerns remain beside BPC-157, CJC-1295 and other ingredients covered by those requests.
Taking back the request leaves the rules for pharmacy use in place. It did not create permission to use that ingredient, as checked September 26, 2026.
FDA’s ingredient recordTake the exact ingredient name to your sport’s rules staff.
Ask them to check the descriptions of banned groups as well as the named examples.
WADA’s list in forceKeep the college body’s list to hand when discussing a treatment with your sports staff.
The NCAA listThe rules doctors must obey come from state law. The national medical-board group’s advice is a suggested approach, as checked September 26, 2026.
Medical boards on telehealthLeave a care discussion with the product name, the reason for choosing it, the full bill and clear instructions for sending later questions.
Back to the beginning